financetom
Business
financetom
/
Business
/
Lyft Stock Is Moving Higher Monday: Here's Why
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lyft Stock Is Moving Higher Monday: Here's Why
Feb 10, 2025 7:58 AM

Lyft Inc ( LYFT ) shares are trading higher Monday following a report indicating the company could launch robotaxis as soon as 2026.

What To Know: Lyft ( LYFT ) is planning to bring a fully autonomous robotaxi service to its app in collaboration with Mobileye Global Inc ( MBLY ) as soon as 2026, according to TechCrunch.

The company plans to test the service in Dallas to start with more markets expected to follow.

Japanese conglomerate Marubeni will reportedly own and finance the Mobileye-equipped vehicles set to become available for rides on Lyft’s mobile app. Lyft ( LYFT ) has not disclosed an OEM partner for the launch or said how many vehicles will be launched in Dallas for the initial rollout.

The news comes a day ahead of Lyft’s fourth-quarter financial results. Analysts expect the company to report earnings of 22 cents per share and revenue of $1.56 billion, according to estimates from Benzinga Pro.

Check This Out: Lyft Faces Growing Competition, Bank of America Analyst Warns

Last quarter, Lyft ( LYFT ) shares surged after the company reported better-than-expected financial results as gross booking grew 16% year-over-year and active riders and rides reached new all-time highs.

“Going forward, our work with best-of-breed partners and the autonomous future we’re building will give people even more reasons to choose Lyft ( LYFT ) every time,” CEO David Risher said at the time.

Lyft ( LYFT ) guided for full-year 2024 rides growth in the mid-teens on a year-over-year basis, and fourth-quarter gross bookings up 15% to 17%. Adjusted EBITDA is expected to be between $100 million and $105 million in the fourth quarter and full-year free cash flow is expected to exceed $650 million.

LYFT Price Action: Lyft ( LYFT ) shares were up 4.48% at $14.81 at the time of publication Monday, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Thomson Reuters Q1 Operating Profit Rises, Lifts 2024 Revenue Outlook
Thomson Reuters Q1 Operating Profit Rises, Lifts 2024 Revenue Outlook
May 2, 2024
07:16 AM EDT, 05/02/2024 (MT Newswires) -- Thomson Reuters ( TRI ) on Thursday reported higher Q1 operating profit on higher revenue. The content and software provider reported that operating profit for the quarter ended March 31 was US$556 million, 10% higher than the US$508 million for the same three months last year. Diluted earnings per share fell 33%, from...
Exelon's Q1 Adjusted Earnings Decline, Operating Revenue Increases
Exelon's Q1 Adjusted Earnings Decline, Operating Revenue Increases
May 2, 2024
07:17 AM EDT, 05/02/2024 (MT Newswires) -- Exelon ( EXC ) reported Q1 adjusted earnings Thursday of $0.68 per diluted share, down from $0.70 a year earlier. Analysts polled by Capital IQ expected $0.70. Operating revenue for the quarter ended March 31 was $6.04 billion compared with $5.56 billion a year earlier. Analysts polled by Capital IQ expected $5.62 billion....
Becton, Dickinson's Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Outlook Revised
Becton, Dickinson's Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Outlook Revised
May 2, 2024
07:18 AM EDT, 05/02/2024 (MT Newswires) -- Becton, Dickinson ( BDX ) reported fiscal Q2 adjusted earnings Thursday of $3.17 per diluted share, up from $2.86 a year earlier. Analysts polled by Capital IQ expected $2.97. Revenue for the quarter ended March 31 was $5.05 billion, compared with $4.82 billion a year ago. Analysts surveyed by Capital IQ expected $5.04...
Zimmer Biomet Holdings Q1 Adjusted Earnings, Net Sales Rise; 2024 Outlook Reiterated
Zimmer Biomet Holdings Q1 Adjusted Earnings, Net Sales Rise; 2024 Outlook Reiterated
May 2, 2024
07:19 AM EDT, 05/02/2024 (MT Newswires) -- Zimmer Biomet Holdings ( ZBH ) reported Q1 adjusted earnings Thursday of $1.94 per diluted share, up from $1.89 a year earlier. Analysts polled by Capital IQ expected $1.87. Net sales for the quarter ended March 31 were $1.89 billion, up from $1.83 billion a year earlier. Analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved